New Products

  • Product Details

Product Information

Product name

Copper Peptide ; CHK-Cu



Molecular Formula


Molecular Weight


Quality Standard

98% by HPLC


Blue Powder

COA of Copper Peptide (GHK-Cu)

Test Items




Blue powder

Blue powder

Identity by MS






Purity (HPLC)



Cu+ content




Store at 2-8 °C,keep dry and dark.

Conclusion: Meets our enterprise standard


Usage of Copper Peptide (GHK-CU) 49557-75-7

·         Accelerate wound repair

·         Increase skin re-epithelialization

·         Reverse aging effects on skin

·         thickens skin, improves elasticity, and increases the subcutaneous fat layer

·         Improve hair transplant success, prevent hair loss

·         GHK analogs with fatty residue analogs increase hair follicle size, stimulate hair growth and reduce hair loss

·         Heal injure intestinal linings. Activates skin's main antioxidant protein – superoxide dismutase

Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

LIRAGLUTIDE 204656-20-2
Product Information Product name Liraglutide Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CAS No. 204656-20-2 Molecular Formula C172H265N43O51 Molecular Weight 3751.20 Storage  2~8℃ Appearance White to off-white crystalline powder COA of Liraglutide Test Specification Results Appearance: White to off-white crystalline powder or lumps White powder Identity: 3751.2±1.0 3751.1 Purity (By HPLC) : Not Less than 98.0%; 99.51% Residual solvents: ≤0.25%total; ≤0.1%individual; ≤0.01%CH2CN Complies Related Peptide Total Impurity ≤ 2.0% Largest Single Impurity ≤ 1.0% TI =0.41% LSI =0.25% Peptide Content: Not Less than 85.0% 87.7% Water (K.F.): Not more than 5% 4.2% Acetate acid: Not more than 10% 8.1% Bacterial Endotoxins Not more than 50IU/mg Complies Usage Function and Usage of Liraglutide 204656-20-2 1、 Type 2 diabetes Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion. In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes: ·         Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia. ·         Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies). ·         Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride. ·         Liraglutide lowers blood triglyceride levels. 2、Obesity Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. The specified criteria are an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight), in the presence of at least one weight-related comorbid condition (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled, multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in the placebo group.
Product Information β-Nicotinamide mononucleotide is a product of the extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) reaction and a key NAD+ intermediate. It ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. It also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation. Name Nicotinamide Mononucleotide Alias BETA-NICOTINAMIDE MONONUCLEOTIDE;   NMN;β-D-NMN; BETA-NMN; NICOTINAMIDE RIBOTIDE; Nicotinamide nucleotide; Nicotinamide mononucleotide; NICOTINAMIDE MONONUCLEOTIDE; NicotinaMide Ribonucleotide; B-NICOTINAMIDE MONONUCLEOTIDE; BETA-NICOTINAMIDE MONONUCLEOTIDE CAS NO. 1094-61-7 Molecular Formula C11H15N2O8P Quality Standard with High Purity 98.0%min Grade Standard Food grade  / 98% min Package Size 1kg/bag, 5kg/bag, or as per customers’ requirements. Usage 1. Nicotinamide mononucleotide in human cells play an important role in energy generation, it is involved in intracellular NAD (nicotinamide adenine dinucleotide, cell energy conversion important coenzyme) synthesis, used in anti-aging, fall blood sugar and other health care products. 2. Nicotinamide Mononucleotide is a water-soluble vitamin, The product is white crystalline powder, odorless or nearly odorless, bitter in taste, freely soluble in water or ethanol, dissolvable in glycerin. 3. Nicotinamide Mononucleotide is easy to absorb oral, and can be widely distributed in the body, the excess metabolites or prototype quickly expel from urine. Nicotinamide is part of coenzyme I and coenzyme II plays the role of hydrogen delivery in biological oxidation respiratory chain, can promote biological oxidation processes and tissue metabolism, maintain normal tissue (especially the skin, digestive tract and nervous system) integrity has an important role. In addition, nicotinamide has prevention and treatment of heart block, sinus node function and anti-fast experimental arrhythmias, nicotinamide can significantly improve the heart rate and atrioventricular block caused by verapamil. COA of Nicotinamide Mononucleotide Items Specification Results Appearance White to pale yellow crystalline powder White crystalline powder Appearance of solution (5% w/v in water) Colorless to pale yellow and clear Colorless and clear Water ≤6.0% 0.5% Arsenic ≤1 PPM < 1 PPM Lead ≤1 PPM < 1 PPM Mercury ≤1 PPM < 1 PPM Heavy Metal ≤10 PPM < 10 PPM Assay(Dry basis) 97.0% - 100.0% 98.1% Conclusion: The product conforms with the enterprise standard.
MINOXIDIL 38304-91-5
GMP , USP, Cosmetic Grade
99% up by HPLC, medical grade
MUPIROCIN 12650-69-0
99% up / GMP
OXALIPLATIN 61825-94-3
EP7.2 , Medical Grade
TEA TREE OIL 68647-73-4
100% , Cosmetic Grade
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.